Brucella species, particularly B. melitensis and B. suis, are potential agents of biological terrorism (1,2 ). This report describes the public health and law enforcement assessment of a suspected case of brucellosis in a woman, in which the atypical clinical presentation and suspicious circumstances surrounding the case raised the possibility of biological terrorism. Although the investigation did not identify evidence of biological terrorism, the safe resolution of the case illustrates the value of integrated clinical, public health, and law enforcement biological terrorism preparedness and response.
agent or other unusual or unexplained illness. These aspects include 1) sensitive, specific, and rapid laboratory diagnosis of patients and characterization of biological agents; 2) early detection through improved surveillance; 3) effective communication; and 4) coordinated local, state, and federal response in the investigation of unusual events or unexplained illnesses.
Early detection is essential to ensure a prompt response to a biological terrorist event. Local public health authorities must rely on clinicians to recognize and report suspicious or unusual presentations of disease. However, correlating suspicious cases originating from diverse locations or discerning an increase in common presentations above the normal baseline is difficult. As in this case, public health practitioners coordinating disease surveillance may be able to receive reports of rare diseases and to determine whether they are occurring at a higher than normal rate in a large surveillance area.
CDC, in collaboration with local, state, and territorial health departments, is enhancing existing disease surveillance systems for specific diseases that are normally rare in the United States but thought to have a high potential for public health impact if used as biological terrorism agents (5, 6 ) . This is being accomplished by improving training of clinical, laboratory, and public health personnel in recognizing suspicious disease presentations and by expanding of existing, disease-specific surveillance infrastructure. In addition, surveillance is being improved for disease presentations such as acute respiratory distress, hemorrhagic, or meningeal symptoms normally caused by common infectious agents but that could indicate an increase in illnesses caused by a biological agent used in terrorism. Surveillance mechanisms to rapidly assess changes in rates of disease include monitoring of calls to local emergency medical systems, regularly reviewing emergency department discharge diagnoses, and linking infection control practitioner networks.
This report illustrates the dilemmas inherent in laboratory detection of potential agents of biological terrorism. Although the standard laboratory test for Brucella antibody is the tube agglutination test (7 ) , the more rapid simple slide agglutination test is commonly used in commercial and hospital laboratories. The slide agglutination test is 97%-100% sensitive and may be as low as 88% specific (8 ) . However, if used in a population with a low prevalence of disease, even a diagnostic test with 99% specificity will have a low positive predictive value. Because agents high on the list of possible biological terrorism have very low incidence of natural infection in the United States, the risk for a false-positive result is high. Therefore, diagnostic laboratory testing should be integrated with epidemiologic investigation when assessing potential covert biological terrorism events to rule out false-positive laboratory findings. To ensure that evaluation of materials from suspected biological terrorism events or threats is sensitive, specific, and rapid, CDC is working with its public health partners to improve laboratory diagnostic tests for many of the potential agents of biological terrorism and to transfer these diagnostic capabilities to state health department laboratories (6 ) . CDC and other federal, state, and territorial public health laboratories are creating a multilevel Laboratory Response Network for Biological Terrorism that links state and local public health agencies to advanced capacity facilities that collectively maintain state-of-the art capabilities for a wide range of biological agents.
Adoption of Protective Behaviors Among Persons With Recent HIV Infection and DiagnosisAlabama, New Jersey, and Tennessee, 1997-1998
A comprehensive human immunodeficiency virus (HIV) prevention strategy includes knowledge of HIV status, counseling to reduce high-risk behavior, and referral for appropriate care (1 ) . After diagnosis, a substantial percentage of HIV-infected persons reduce their high-risk sexual behaviors (2) (3) (4) . This report presents data characterizing the sexual practices of persons with newly diagnosed HIV infection who have evidence of recently acquired infection. Characterizing these persons may assist in the development of riskreduction efforts for HIV-infected populations to prevent further HIV transmission.
To examine risk behaviors (e.g., condom use and number of sex partners) after HIV diagnosis, CDC analyzed data on HIV testing history and sexual behavior of persons who may have recently acquired HIV infection as part of a CDC-sponsored study in Alabama, New Jersey, and Tennessee. For purposes of this study, criteria for recent HIV infection included persons with diagnosed and reported HIV infection with CD4 T-lymphocyte counts >700 cells/µL or percentage >36, documented HIV seroconversion within 18 months of confirmed HIV infection diagnosis, or persons aged 13-24 years when diagnosed (5 ). Respondents were told that questions about behaviors before they learned of their HIV status concerned sexual activities after 1977 but before the first time respondents were told they were HIV-positive. Questions about behaviors since they learned of their HIV status concerned the period after a doctor, health-care provider, or counselor informed respondents that they were HIV-positive.
During January 1997-September 1998, 615 persons with HIV infection diagnosed and reported met the criteria for the study; these persons represented 15% of all persons with HIV infection diagnosed and reported during this period from Alabama, New Jersey, and Tennessee. Of the 543 persons determined eligible after follow-up by state health departments, 180 (33%) completed interviews, 127 (23%) refused to be interviewed, and 235 (43%) could not be located. Among persons with known dates, 148 (86%) of 173 were interviewed within 12 months of the self-reported date they learned they were HIV-infected (median: 6 months).
Among the 180 persons interviewed, 99 (55%) were female; 96 (53%) were age <25 years; and 105 (58%) were non-Hispanic black, 49 (27%) were non-Hispanic white, 24 (13%) were Hispanic, and two (1%) were self-reported as "other." These demographic characteristics were similar for persons not interviewed. Twenty-three (28%) of 81 males and 69 (70%) of 99 females could not be classified as having recognized transmission risk or as having sexual contact with an HIV-infected partner or one with a documented transmission risk. All except one of these persons reported heterosexual activity but was unaware of the partner's HIV status or risk for HIV infection.
Among 68 males stating a primary reason for being tested, the leading reasons were because a doctor or friend told them to be tested (28%) and because they were worried they might be infected even though they were not sick (22%). Among 90 females stating a primary reason for testing, the leading reasons were because of pregnancy care (33%) and because a doctor or friend told them to be tested (18%). Of 180 persons interviewed, 162 (90%) responded that they had changed their sexual behavior since learning of their HIV infection. Among these persons, 97 (60%) stated they used condoms more often, 80 (49%) did not have sex as often, 58 (36%) had not had sex, 16 (10%) had sex with persons they knew were infected, and eight (5%) had only oral sex. No differences were reported in these behavior changes by sex, except having only oral sex (9% among males and 1% among females).
Among 97 females reporting vaginal sex with males and among 45 males reporting anal sex with males, 25%, 69%, and 6% reported using condoms before diagnosis never, sometimes, and always, respectively. After diagnosis, 30% reported not having sex, and 6%, 11%, and 47% reported never, sometimes, and always using condoms, respectively. Self-reported condom use after learning of HIV infection among a subset of these persons who reported some unprotected sex before HIV diagnosis indicated that a high proportion of males and females adopted protective behaviors (Figure 1 ).
Fifty-two (79%) of 66 females having vaginal sex with men after diagnosis reported having one partner since learning of their HIV infection; 15 (50%) of 30 men having anal sex with men since diagnosis reported having one partner. Among males and females interviewed within 6 months of diagnosis, 41 (44%) of 94 reported not having sex; among males and females interviewed more than 6 months after diagnosis, 14 (18%) of 79 reported not having sex.
Of 180 persons interviewed, 151 (84%) reported receiving medical care for HIV infection since diagnosis. Among the 27 persons who responded that they had not received medical care for their HIV infection since diagnosis, 13 (48%) reported feeling well and not thinking it was important to seek medical care right away, and 12 (44%) reported not wanting to think about being HIV-positive as reasons for postponing seeking health care right away. Twenty-two (81%) of 27 respondents not receiving medical care reported changing their sexual behavior since learning of their HIV infection compared with 139 (93%) of 149 respondents receiving medical care.
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Adoption of Protective Behaviors -Continued
Editorial Note: The findings in this study suggest that a high proportion of infected persons adopted safer sexual behaviors following diagnosis of HIV infection and are consistent with other studies showing adoption of safer behaviors after diagnosis in some groups (2-4 ). The findings also are consistent with a report describing an increase in reported safe behaviors 6 months after beginning HIV-related primary care (6 ) . Because persons who have not had sex since their diagnosis may become sexually active later, sustained interventions must be available for maintenance and adoption of safe behaviors. In this and other studies (7 ), most persons report receiving HIV-related medical care within 1 year of learning of their positive HIV status. These encounters provide an opportunity for behavioral risk-reduction counseling and intervention. Health-care providers should emphasize the need to sustain safe behaviors, especially because persons benefitting from antiretroviral therapy may be living longer, healthier lives and, therefore, may engage in risky sexual activity over time.
The findings in this report are subject to at least five limitations. First, the findings may be biased toward persons receiving medical treatment because this group was easier to Percentage § locate and interview than those not in treatment. Second, face-to-face interviews about sexual behavior may bias results toward socially desirable responses. Third, although this study included many young persons, some older persons may have been sexually active for many years and this analysis did not control for variation in length of time persons had been sexually active before diagnosis. Fourth, although knowledge of laws related to HIV is limited (8 ) , local laws related to knowingly exposing persons may have influenced candid replies to condom-use questions. Finally, this study was conducted as a pilot project in only three states and these findings may not be generalizable.
Young persons and others with evidence of recent HIV infection can provide insights into prevention needs and failures. Areas conducting HIV and AIDS surveillance can characterize persons with recently acquired infection and therefore can describe recent patterns of transmission and risk behaviors. CDC recommends that all states adopt HIV case surveillance to assist in monitoring the epidemic (5 ) .
Of the estimated 800,000-900,000 persons infected in the United States, approximately one third have yet to be diagnosed (5 ) . Most women were unaware of their partner's HIV status and a high percentage were tested related to pregnancy. HIV testing and counseling programs should encourage persons at high risk for HIV infection to seek knowledge of their status and should facilitate referrals to ongoing care and prevention services for persons found to be infected (9 ) . Increasing the availability and improving access to testing in public and private settings early in the course of disease will increase opportunities for sustained prevention and treatment for all HIV-infected persons. . In October 1998, the U.S. Environmental Protection Agency (EPA) was notified of the death of a worker acutely exposed to 2,4-DCP. Follow-up investigation by EPA, the Occupational Safety and Health Administration (OSHA), and CDC's National Institute for Occupational Safety and Health (NIOSH) identified four earlier deaths associated with acute 2,4-DCP exposure, which occurred during 1980-1992. All of these incidents resulted in rapid death after dermal exposure to the heated liquid form of the chemical. This report describes the five deaths associated with 2,4-DCP exposure (presented in the order in which they were identified) and provides recommendations for preventing additional deaths.
Case Reports
Case 1. On October 12, 1998, a 29-year-old man employed at a Michigan chemical company producing 2,4-D was sprayed with 2,4-DCP from a leak in tubing while he was using steam to clear a blocked pump. The worker bypassed the nearest safety shower and used a locker room shower, where he became unconscious. Resuscitation attempts were unsuccessful, and the worker was pronounced dead at a hospital 1 hour after exposure. Skin surfaces exposed to 2,4-DCP included his forearms, right knee, right thigh, and face. Except for chemical burns on his face and extremities and pulmonary edema, the autopsy findings were unremarkable. 2,4-DCP was found in his blood (7.2 mg/ L free 2,4-DCP, 13.1 mg/L total 2,4-DCP) and urine (4.8 mg/L free 2,4-DCP, 6.2 mg/L total 2,4-DCP). Death was attributed to acute dichlorophenol intoxication.
Case 2. In 1991, a 33-year-old man working at a factory in France was splattered over portions of his right thigh and arm with pure liquid 2,4-DCP while disposing of industrial waste (1 ) . He walked away from the scene and washed himself with water without undressing. He experienced a seizure, collapsed within 20 minutes of exposure, and died after unsuccessful attempts at resuscitation. 2,4-DCP was found in his blood (24.3 mg/L), urine (5.3 mg/L), bile (18.7 mg/L), and stomach (1.2 mg/L).
Case 3. In September 1980, a 45-year-old man working at the same facility as the decedent in case 1 sustained skin and upper-airway exposure after being sprayed by steam containing 2,4-DCP. The worker bypassed the nearest safety shower, started decontamination using an unalarmed shower in a dressing area, and then moved to an alarmed shower, which automatically notified emergency personnel and summoned an ambulance. He sustained thermal burns to his skin, mouth, and upper airway, lost consciousness, and died despite resuscitation attempts. An autopsy revealed cutaneous burns on his neck, upper chest, back, and thighs; pulmonary congestion with alveolar hemorrhage; and moderately severe hepatocellular fatty change. His larynx was congested in a manner consistent with a steam/chemical burn, but the trachea was unremarkable, suggesting only upper airway exposure to the steam and 2,4-DCP. No reliable data on 2,4-DCP concentration in biologic fluids were available.* The final pathologic diagnosis was "acute steam and dichlorophenol exposure." *Analytic methods used to measure 2,4-DCP in biologic fluids were developed after 1980. Case 5. In April 1985, a 33-year-old man working at an Arkansas manufacturing facility was splashed with a solution containing 51% 2,4-DCP † while moving a hose used to transfer the material. The solution covered 60%-65% of his body surface area (head, chest, neck, abdomen, arms, and thighs). When paramedics arrived, he was unconscious and convulsing on the shower room floor. He was transported to a hospital and pronounced dead approximately 90 minutes after exposure. An autopsy revealed firstdegree chemical burns on exposed skin surfaces; swollen, red, sloughed mucosa of the larynx, trachea, and bronchi; focal hemorrhage and considerable hemorrhagic frothy fluid in the lungs (with fluid extruding through his mouth and nostrils); blue/tan swollen esophageal mucosa; and reddened mucosa and turbid hemorrhagic fluid in the stomach. Microsections of the brain revealed intense congestion and petechial hemorrhages. Serum total dichlorophenol concentration at postmortem was 67 mg/L. The final pathologic diagnosis was "acute chlorinated phenolic exposure and 60% chemical burns." Editorial Note: 2,4-DCP is a white solid at room temperature, but liquifies at 111 F-116 F (43 C-45 C). The liquid is rapidly absorbed through the skin. 2,4-DCP is not believed to be used outside the chemical industry, although small amounts may be present in drinking water when chlorination converts other phenolic compounds into this chemical (4 ) . An estimated 200 U.S. workers are potentially exposed to 2,4-DCP. As of 1998, at least eight U.S. facilities were known to use or handle 2,4-DCP. Annual worldwide production is estimated at 88 million pounds (5 ) . No OSHA, NIOSH, or American Conference of Governmental Industrial Hygienists exposure limits exist for 2,4-DCP.
The mechanism by which 2,4-DCP causes death is uncertain, but this and other chlorinated phenols are known to uncouple oxidative phosphorylation (6 ) . Most production of adenosine triphosphate, the carrier of free energy in cells, occurs through oxidative phosphorylation. Uncoupling oxidative phosphorylation at the mitochondrial level leads to profound disturbance of energy production and may have caused the rapid deaths described in this report. A characteristic sequence of signs in animals given lethal doses of solid 2,4-DCP is consistent with the clinical progression noted in these cases and includes tremors, muscle weakness, loss of coordination, clonic convulsions, dyspnea, coma, and respiratory arrest (4 ). Although three of the decedents in this report also were exposed to steam, the reported symptoms and autopsy findings suggest that steam exposure did not play a substantial role in these deaths. Finally, postmortem drug screens were negative in all five cases, which excludes interaction with a drug or medication as a potential explanation for the deaths.
Potentially exposed workers, their supervisors, and health and safety staff should be aware of the hazards associated with exposure to 2,4-DCP, especially when the chemical is in the liquid state. In an April 1999 letter and a February 2000 chemical advisory (7 ) , † This solution also contained (in order of diminishing proportion) parachlorophenol, orthochlorophenol, monochloroacetic acid, 2,6-dichlorophenol, phenol, and 2,4,6-trichlorophenol.
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2,4-DCP Exposure -Continued EPA and OSHA notified facilities believed to use 2,4-DCP of these fatalities and provided recommendations to prevent additional morbidity and mortality. Standard safe work procedures should be developed and disseminated to workers involved in tasks having potential 2,4-DCP exposure. Engineering controls and source reduction methods should be adopted to eliminate the potential for exposure. Detailed recommendations for appropriate protective clothing for dermal protection and respirators for inhalation protection were specified in the EPA/OSHA chemical advisory (7 ) . Health and safety staff decontaminating exposed workers should wear appropriate personal protective equipment and should participate in drills to ensure proficiency while wearing this gear. Any skin contact with liquid 2,4-DCP should be considered a life-threatening medical emergency. Safety showers should be located in the immediate vicinity of work areas having potential for 2,4-DCP exposure. These showers should be alarmed so that assistance is summoned promptly. Exposed skin should be flushed for at least 15 minutes, and contaminated clothing must be removed. Because 2,4-DCP is lipophilic and has relatively low water solubility (7 ), the use of water for skin flushing may lead to a protracted decontamination process. Additional research is needed to identify more effective agents for skin decontamination. Treatment for 2,4-DCP intoxication is supportive, and there is no known antidote.
Erratum: Vol. 49, No. 17
In the article, "Morbidity and Mortality Associated With Hurricane Floyd-North Carolina, September-October 1999," on page 371, a name was misspelled in the "Reported by" section: J Dolzinger, MD, Pitt Memorial Hospital, Greenville, North Carolina, should be J Dolezal. Also, a credit was missing: S Lynn, North Carolina Dept of Health and Human Svcs. 
U: Unavailable.
-: No reported cases. *Individual cases can be reported through both the National Electronic Telecommunications System for Surveillance (NETSS) and the Public Health Laboratory Information System (PHLIS). † Cumulative reports of provisional tuberculosis cases for 1999 are unavailable ("U") for some areas using the Tuberculosis Information System (TIMS). 
